Fed. Circ. Upholds Genzyme’s Win In Stem Cell Patent Case – Law360
|
Fed. Circ. Upholds Genzyme's Win In Stem Cell Patent Case
Law360 Law360, New York (December 18, 2017, 7:04 PM EST) — The Federal Circuit on Monday affirmed a Delaware federal judge's finding in a bench trial that a Genzyme Corp. patent on harvesting stem cells is valid, leaving in place a ruling that barred generic … |
